Comments on “Mesenchymal Stem Cells versus Placebo for Perianal Fistulizing Crohn’s Disease: A Systemic Review and Meta-Analysis”

Abstract

Get full access to this article

View all access options for this article.

References

Liu

. Mesenchymal stem cells versus placebo for perianal fistulizing Crohn’s disease: A systemic review and meta-analysis. Surg Innov. 2023;30(3):398-405.

Wang

Jiang

Zhang

Jin

Fei

Jiang

. Mesenchymal stem cells transplantation for perianal fistulas: A systematic review and meta-analysis of clinical trials. Stem Cell Res Ther. 2023;14(1):103. Published 2023 Apr 26.

Lightner

Wang

Zubair

Dozois

. A systematic review and meta-analysis of mesenchymal stem cell injections for the treatment of perianal Crohn’s disease: Progress made and future directions. Dis Colon Rectum. 2018;61(5):629-640.

Duijvestein

Molendijk

Roelofs

, et al. Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease. Cytotherapy. 2011;13(9):1066-1073.

Cheng

Huang

. Mesenchymal stem-cell therapy for perianal fistulas in Crohn’s disease: A systematic review and meta-analysis. Tech Coloproctol. 2019;23(7):613-623.